Extra, Extra

Enemies, a Love Story: “Just three days after President Donald Trump sketched out an idea to meet with North Korea’s Kim Jong Un again, Kim responded by accepting a different kind of invitation — to Beijing, where he will join Russia’s Vladimir Putin and China’s Xi Jinping in a show of defiance against the Western-led global order.” With Russia’s help, North Korea expands its nuclear weapons capability.

+ America, ICU: Mom of Minneapolis school shooting victim was working in ICU when injured daughter arrived.

+ Be There in Ten: “It’s a model that has burned through mountains of cash — and flamed out — in nearly every other major market. Yet investors are betting that India will be different. With dense cities, low labor costs, and a rising class of more than 730 million digital-first Gen Z and millennial consumers accustomed to instant services, the country may be the one place where 10-minute delivery can finally work at scale.” Bloomberg (Gift Article): World’s Fastest Deliveries Ignite an Investment Frenzy in India.

+ Poison Pill: “The law’s Medicaid cuts, which finance lower taxes for the wealthy, will deprive millions of Americans of health insurance. These changes will harm people with all sorts of medical conditions. Yet addicts are particularly vulnerable because of how many of them are on Medicaid.” America Was Finally Turning a Corner on Opioids. Until Now.

+ Spy Kids: I’m a Stanford student. A Chinese agent tried to recruit me as a spy. (Cal students would never go for this!)

+ Dry ICE: NYT (Gift Article): “Some misaligned sprinklers as well as over-irrigation causing some run-off … Water is making its way from the property and down the gutter.” These investigators patrol Las Vegas looking for one thing: water waste.

+ Dead Body of Work: “The digital afterlife industry, which manages a person’s digital assets after their death, is expected to quadruple in size to nearly $80 billion over the next decade. That includes the creation of deadbots. The more immersive these bots become, the more technology companies are exploring their commercial potential, causing concern in the research community and elsewhere.” AI ‘deadbots’ are persuasive — and researchers say they’re primed for monetization. (I wonder if there’s a way I could have my deadbot take over writing this newsletter while I’m still alive…)